Britannia Life Sciences Inc. is pleased to provide its unaudited financial results for the three- and six- month periods ended September 30, 2023. These filings and additional information.
Toronto, Ontario (Newsfile Corp. - August 30, 2022) - Britannia Life Sciences Inc. (CSE: BLAB) ("Britannia" or the "Company") is pleased to provide its unaudited financial results for the three months
Proceeds to be used to repay Sellers' Note and acquire an additional 10% of ADSLFive-year term provides Company with significant financial flexibility5 year term, 9.5% interest rate, no equity kickersToronto